ArticleKidney medicine2026
Reproductive Planning and Preconception Counseling in Kidney Disease (REPKID):A Cross-Sectional Survey.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale & Objective: Chronic kidney disease (CKD) increases risks of adverse maternal and fetal outcomes. Preconception counseling (PCC) aims to minimize health risks by optimizing prepregnancy health and modifiable risk factors. Although PCC is recommended for all patients, PCC's utilization and impact among patients with CKD are unknown. This study identified the current utilization and impact of PCC among patients with CKD at an urban academic medical center. Study Design: This survey-based study evaluated patients' self-reported demographic characteristics, kidney disease history, PCC exposure and understanding, and interactions with the health care system. Setting & Participants: Participants included 108 patients assigned female sex at birth and aged 18-45 years at an urban, academic nephrology clinic surveyed between January and May 2024. Exposures: Exposures of interest included sociodemographic characteristics, clinical CKD presentation, and health care utilization patterns. Outcomes: The primary outcome was self-reported receipt of PCC. Secondary outcomes included the specialty of the provider offering PCC, specific PCC topics discussed, and patient-reported levels of concern and knowledge. Analytical Approach: Cross-sectional analysis used χ Results: Overall, 74% of respondents reported receiving PCC. PCCs from a maternal-fetal medicine provider were more likely to discuss medication safety, childbearing plans, and maternal and fetal complications. PCC recipients also reported greater concern about fertility but less knowledge about preconception and pregnancy with CKD. Limitations: Findings may lack generalizability given the single-center, English-speaking population and potential recall bias from self-reported data. Conclusions: As PCC is recommended for all patients, especially those with a comorbid condition, PCC for patients with CKD remains suboptimal, with 26% reporting no PCC. Differing discussion topics between maternal-fetal medicine and nephrologists suggest a need for PCC standardization and equitable access to multidisciplinary specialists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.